Mar 3
TSHA · Taysha Gene Therapies, Inc. · Documents
$3.99
-0.01 (-0.25%)
At close · Nov 18
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.30B
Shares
326.05M
Volume · Nov 18
3.55M
Avg daily vol (3M)
3.62M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2021
Feb 12
Current report
8-K
Events of Feb 9
Other events
Feb 1
Current report
8-K
Other events
Jan 19
Current report
8-K
Other events
Jan 15
Current report
8-K
Events of Jan 11
Entered into a material agreement, New debt or off-balance-sheet obligation
2020
Dec 21
Current report
8-K
Other events
Dec 17
Dec 3
Current report
8-K
Other events
Nov 24
Current report
8-K
Events of Nov 23
Director or officer change, or executive pay, Regulation FD disclosure
Nov 12
Current report
8-K
Completed an acquisition or sale of assets
Nov 12
Nov 5
Current report
8-K
Other events
Nov 4
Current report
8-K
Events of Oct 29
Entered into a material agreement
Oct 27
Current report
8-K
Other events
Oct 14
Current report
8-K
Other events
Oct 7
Current report
8-K
Events of Oct 6
Other events
Sep 29
Current report
8-K
Events of Sep 28
Charter or bylaw amendment, or fiscal year change
Sep 18
Registration statement
S-1/A
Registration statement
Sep 17
Registration statement
S-1/A
Registration statement
Sep 8
Registration statement
S-1/A
Registration statement
Sep 2
Registration statement
S-1
Registration statement
Showing 151–171 of 171 documents
Key facts
CIK
1806310
CUSIP
877619106
13F (30d)
217 filings
199 filers
Visit website
Investor relations